Low Odds of U.S. Drug Pricing Reforms Create Favorable Valuations
Democratic presidential candidates' potential drug policy reforms have pressured drug stocks, and ongoing political campaigns are likely to...
1.7k Views
Actelion / Johnson & Johnson: Tendered Vs Untendered Lines
Any deal-threatening risks to the Actelion / Johnson & Johnson transaction were assuaged in late March and we now solely await EC antitrust...
452 Views
Actelion / Johnson & Johnson: Trading Idorsia, the R&D NewCo Spin-Off
J&J recent declared its tender offer for Actelion successful and we are now in the midst of the additional acceptance period which runs from...
630 Views